Urology · Tracy, CA
NPI
1851368054
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2160 W Grant Line Rd, Suite 140
Tracy, CA, 95377
Phone (209) 833-3449
Groups this clinician bills Medicare through
Medicare paid, 2024
$364K
5,369 services
Medicare patients, 2024
557
Average age 75
Drug cost, 2024
$216K
2,724 prescriptions
Company payments, 2025
$94.13
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salman Razi was code 81002 (clinical chemistry), 643 times for 395 patients. In total Salman Razi billed 5,369 services in 63 codes, and Medicare paid $364K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 643 | 395 | $3.41 | $2,193 |
| 51798 Ultrasound - Nonspecific | Office | 435 | 326 | $8.77 | $3,814 |
| 99213 Office E&M - Established | Office | 368 | 229 | $66.29 | $24K |
| 99214 Office E&M - Established | Office | 309 | 267 | $91.70 | $28K |
| 96372 Injection Administration | Office | 136 | 85 | $12.08 | $1,642 |
| 52000 Cystourethroscopy | Office | 131 | 114 | $191.84 | $25K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 124 | 16 | $139.47 | $17K |
| 99203 Office E&M - New | Office | 118 | 118 | $82.86 | $9,777 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 100 | 81 | $1.98 | $198 |
| 52442 Cystourethroscopy | Office | 87 | 17 | $756.13 | $66K |
| 99204 Office E&M - New | Office | 74 | 74 | $116.93 | $8,653 |
| 51741 Test - Miscellaneous | Office | 67 | 66 | $6.16 | $413 |
| 99212 Office E&M - Established | Office | 66 | 47 | $43.75 | $2,887 |
| 51729 Other Organ Systems | Office | 65 | 64 | $322.81 | $21K |
| 51797 Other Organ Systems | Office | 64 | 63 | $163.25 | $10K |
By year: 2022 $463K for 4,656 services; 2023 $398K for 4,058 services; 2024 $364K for 5,369 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 643 | 395 | $3.41 | $2,193 |
Medicare prescription drug claims, 2024
In 2024, the drug Salman Razi prescribed most often to Medicare patients was Finasteride, with 647 prescriptions and refills. In total Salman Razi wrote 2,724 Medicare prescriptions that cost $216K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 647 | 1,851 | 233 | $11K |
| Tamsulosin Hcl Generic | 516 | 1,417 | 196 | $7,659 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 508 | 524 | 331 | $946 |
| Ciprofloxacin Hcl Generic | 237 | 237 | 175 | $565 |
| Myrbetriq Mirabegron | 158 | 334 | 49 | $144K |
| Oxybutynin Chloride Generic | 112 | 219 | 34 | $1,784 |
| Tolterodine Tartrate Generic | 95 | 245 | 42 | $9,042 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 70 | 70 | 67 | $286 |
| Bicalutamide Generic | 49 | 94 | 12 | $1,174 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 46 | 46 | 33 | $382 |
| Doxazosin Mesylate Generic | 44 | 119 | 18 | $631 |
| Cephalexin Generic | 25 | 62 | 11 | $320 |
| Trospium Chloride Er Trospium Chloride | 24 | 55 | 12 | $5,941 |
| Dutasteride Generic | 15 | 37 | Under 11 | $357 |
| Gemtesa Vibegron | 14 | 34 | 11 | $16K |
Brand drugs: - claims; generic drugs: 2,518 claims; opioid claims: 82.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salman Razi $94.13 ($94.13 in general payments such as food, travel and fees) from 2 companies. The largest payer was Teleflex LLC with $76.58.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 3 | $76.58 |
| Agiliti Surgical, Inc. | 1 | $17.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.